Spotlight Presentation: Advancing Immunotherapy Programs with Meso Scale Discovery Biomarker Assays
29 Oct 2024
Immunogenicity
,
Translational Immunology
,
Clinical Development
,
Immune Regulation
)
MSD biomarker assays are enabling development of immunotherapies and enhancing pre-clinical and clinical efficacy and safety studies. MSD’s biomarker product platforms, V-PLEX, U-PLEX, R-PLEX and S-PLEX offer robust singleplex and multiplex measurements from a diverse array of sample types including cell culture, serum, plasma and tumor homogenates. Alongside a comprehensive catalog of biomarker and cytokine assays, researchers are harnessing MSD's unique advantages to expedite custom assay needs in immunogenicity, PK, auto-antibody, and serology studies.
